10344033

Source:http://linkedlifedata.com/resource/pubmed/id/10344033

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0016018
pubmed:dateCreated	1999-6-10
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9712380
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Fibrinolytic Agents
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	1368-504X
pubmed:author	pubmed-author:VerheugtFF
pubmed:issnType	Print
pubmed:volume	99
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	3-5
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:10344033-Cerebral Hemorrhage, pubmed-meshheading:10344033-Clinical Trials as Topic, pubmed-meshheading:10344033-Fibrinolytic Agents, pubmed-meshheading:10344033-Humans, pubmed-meshheading:10344033-Myocardial Infarction, pubmed-meshheading:10344033-Thrombolytic Therapy
pubmed:year	1998
pubmed:articleTitle	What should a new thrombolytic bring us?
pubmed:affiliation	Department of Cardiology, Academisch Ziekenhuis Nijmegen, The Netherlands.
pubmed:publicationType	Journal Article, Review